CTI BioPharma Corp. Pre-Tax Profit Margin 2010-2023 | CTIC
CTI BioPharma Corp. pre-tax profit margin from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-03-31 | $0.08B | $-0.07B | -92.00% |
| 2022-12-31 | $0.05B | $-0.09B | -175.47% |
| 2019-09-30 | $0.02B | $-0.03B | -182.35% |
| 2019-06-30 | $0.02B | $-0.04B | -225.00% |
| 2019-03-31 | $0.02B | $-0.04B | -211.76% |
| 2018-12-31 | $0.03B | $-0.03B | -107.41% |
| 2018-09-30 | $0.01B | $-0.04B | -338.46% |
| 2018-06-30 | $0.01B | $-0.04B | -292.86% |
| 2018-03-31 | $0.04B | $-0.03B | -71.43% |
| 2017-12-31 | $0.03B | $-0.04B | -164.00% |
| 2017-09-30 | $0.03B | $-0.03B | -100.00% |
| 2017-06-30 | $0.04B | $-0.05B | -141.67% |
| 2017-03-31 | $0.02B | $-0.08B | -361.90% |
| 2016-12-31 | $0.06B | $-0.05B | -94.64% |
| 2016-09-30 | $0.06B | $-0.07B | -124.14% |
| 2016-06-30 | $0.06B | $-0.08B | -138.18% |
| 2016-03-31 | $0.05B | $-0.09B | -181.63% |
| 2015-12-31 | $0.02B | $-0.12B | -756.25% |
| 2015-09-30 | $0.02B | $-0.14B | -595.65% |
| 2015-06-30 | $0.06B | $-0.10B | -161.29% |
| 2015-03-31 | $0.06B | $-0.09B | -151.61% |
| 2014-12-31 | $0.06B | $-0.09B | -156.67% |
| 2014-09-30 | $0.08B | $-0.04B | -56.00% |
| 2014-06-30 | $0.04B | $-0.06B | -177.14% |
| 2014-03-31 | $0.03B | $-0.05B | -155.88% |
| 2013-12-31 | $0.03B | $-0.04B | -129.41% |
| 2010-12-31 | $0.00B | $-0.08B | inf% |
| 2010-06-30 | $0.00B | $-0.11B | inf% |
| 2010-03-31 | $0.00B | $-0.11B | inf% |
| 2009-12-31 | $0.00B | $-0.10B | inf% |
